Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0025 Transporter Info
Gene Name SLC22A8
Transporter Name Organic anion transporter 3
Gene ID
9376
UniProt ID
Q8TCC7
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Probenecid

          11 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the transportation of Cimetidine by SLC22A8 (IC50 = 3.1 microM) [1]

Affected Drug/Substrate

 Cimetidine Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 2

 Probenecid inhibits the transportation of Dimesna by SLC22A8 (Ki = 32 microM) [2]

Affected Drug/Substrate

 Dimesna Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-OAT3

  DT Modulation 3

 Probenecid inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 9 microM) [3]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 4

 Probenecid inhibits the transportation of Fexofenadine by SLC22A8 (Ki = 1.3 microM) [4]

Affected Drug/Substrate

 Fexofenadine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  DT Modulation 5

 Probenecid inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 4.41 microM) [5]

Affected Drug/Substrate

 Ochratoxin A Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 6

 Probenecid inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 5.6 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 7

 Probenecid inhibits the transportation of Estrone sulfate by SLC22A8 [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  DT Modulation 8

 Probenecid inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 9

 Probenecid inhibits the activity of SLC22A8 [1] , [8]

  DT Modulation 10

 Probenecid blocks the activity of SLC22A8 [9] , [10]

  DT Modulation 11

 Probenecid inhibits the activity of SLC22A8 [21]

  Bumetanide

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bumetanide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.75 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Bumetanide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.8 microM) [13]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Oocytes-OAT3

  DT Modulation 3

 Bumetanide inhibits the transportation of Methotrexate by SLC22A8 (IC50 = 5.4 microM) [13]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Oocytes-OAT3

  Furosemide

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Furosemide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.31 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Furosemide inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 1.7 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 3

 Furosemide inhibits the activity of SLC22A8 [1] , [16]

  Ibuprofen

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ibuprofen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 6 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Ibuprofen inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 3.7 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 3

 Ibuprofen inhibits the activity of SLC22A8 [1] , [16]

  Cefadroxil

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefadroxil inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 8620 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Cefadroxil inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 3

 Cefadroxil inhibits the transportation of Estrone sulfate by SLC22A8 [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

  Piroxicam

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Piroxicam inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 2.52 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Piroxicam inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 4.88 microM) [5]

Affected Drug/Substrate

 Ochratoxin A Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Fluvastatin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fluvastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 5.79 microM) [19]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Fluvastatin inhibits the activity of SLC22A8 [19]

  Simvastatin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Simvastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 32.3 microM) [19]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Simvastatin inhibits the activity of SLC22A8 [19]

  Sulfasalazine

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfasalazine inhibits the transportation of Methotrexate by SLC22A8 (IC50 = 3 microM) [13]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Oocytes-OAT3

  DT Modulation 2

 Sulfasalazine inhibits the activity of SLC22A8 [13]

  Gemfibrozil

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gemfibrozil inhibits the transportation of Pravastatin by SLC22A8 (IC50 = 6.8 microM) [20]

Affected Drug/Substrate

 Pravastatin Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Gemfibrozil inhibits the activity of SLC22A8 [22]

  Sitagliptin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sitagliptin inhibits the transportation of Cimetidine by SLC22A8 (IC50 = 160 microM) [1]

Affected Drug/Substrate

 Cimetidine Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Betamipron

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Betamipron inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 48.3 microM) [3]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cilastatin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cilastatin inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 231 microM) [3]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Cilastatin inhibits the uptake of diclofenac acyl glucuronide by SLC22A8 [32]

Affected Drug/Substrate

 Diclofenac acyl glucuronide Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Acetazolamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetazolamide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 816 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Chlorothiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlorothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 65.3 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cyclothiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 27.9 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Ethacrynic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethacrynic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.58 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Hydrochlorothiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydrochlorothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 942 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Methazolamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methazolamide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 97.5 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Trichlormethiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trichloromethiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 71.2 microM) [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Novobiocin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Novobiocin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 4.99 microM; Ki = 4.77 microM) [23]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT3

  Diclofenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diclofenac inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.78 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Indomethacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.61 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Ketoprofen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoprofen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 5.98 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Mefenamic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mefenamic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.78 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Naproxen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Naproxen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 4.67 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Sulindac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulindac inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 3.62 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Pravastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pravastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 13.7 microM) [19]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Phenylbutazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenylbutazone inhibits the transportation of Methotrexate by SLC22A8 (Ki = 34.7 microM) [14]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cefamandole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 50 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cefazolin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 550 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cefoperazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 1890 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cefotaxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 290 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Ceftriaxone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 4390 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cephalothin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 40 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cimetidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cimetidine inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 79 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Fenofibric acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fenofibric acid inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 2.2 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Indapamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indapamide inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 11 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Quinapril

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quinapril inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 6.2 microM) [1]

Affected Drug/Substrate

 Sitagliptin Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Piperacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Piperacillin inhibits the transporation of tazobactam by SLC22A8 (IC50 = 89.04 microM; Ki = 172 microM) [29]

Affected Drug/Substrate

 Tazobactam Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)

  Candesartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Candesartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.3 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Losartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Losartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 1.6 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Olmesartan medoxomil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.027 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Telmisartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Telmisartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 1.6 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Valsartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valsartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.2 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Imipenem

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Imipenem significantly inhibits the uptake of cilastatin by SLC22A8 [31]

Affected Drug/Substrate

 Cilastatin Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Zidovudine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zidovudine inhibits the transportation of Estrone sulfate by SLC22A8 [33]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Linagliptin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Linagliptin inhibits the transportation of Estrone sulfate by SLC22A8 [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Carbenicillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Carbenicillin inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Cefaclor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefaclor inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Dicloxacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicloxacillin inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Oxacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Oxacillin inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  Aspirin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aspirin inhibits the transportation of Cilostazol by SLC22A8 [34]

Affected Drug/Substrate

 Cilostazol Modulation Type Inhibition

  Bendroflumethiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bendroflumethiazide inhibits the transportation of Polycyclic aromatic hydrocarbons by SLC22A8 [35]

Affected Drug/Substrate

 Polycyclic aromatic hydrocarbons Modulation Type Inhibition

  Folic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Folic Acid inhibits the expression of SLC22A8 [37]

  Testosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Testosterone inhibits the expression of SLC22A8 [39]

  Fluorescein

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fluorescein inhibits the activity of SLC22A8 [40]

  Ciprofloxacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ciprofloxacin inhibits the activity of SLC22A8 [41]

  Gatifloxacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gatifloxacin inhibits the activity of SLC22A8 [41]

  Torasemide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Torsemide inhibits the activity of SLC22A8 [42]

  Etoricoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etoricoxib inhibits the activity of SLC22A8 [43]

  Celecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib inhibits the activity of SLC22A8 [44] , [45]

  Rofecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rofecoxib inhibits the activity of SLC22A8 [45]

  Valdecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valdecoxib inhibits the activity of SLC22A8 [45]

  Vancomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vancomycin inhibits the activity of SLC22A8 [46]

  Sulfadiazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfadiazine inhibits the activity of SLC22A8 [47]

  Nitrofurantoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nitrofurantoin inhibits the activity of SLC22A8 [48]

  Metronidazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Metronidazole inhibits the activity of SLC22A8 [49]

  Selexipag

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Selexipag inhibits the activity of SLC22A8 [50]

  Omeprazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Esomeprazole inhibits the activity of SLC22A8 [51]

  Lansoprazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lansoprazole inhibits the activity of SLC22A8 [51]

  Itraconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Itraconazole inhibits the activity of SLC22A8 [52]

  Ketoconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoconazole inhibits the activity of SLC22A8 [52]

Drug Marketed but not Approved by US FDA

  Linoleic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Linoleic Acid inhibits the activity of SLC22A8 [38]

Drug in Phase 4 Trial

  DT Modulation 1

 Benzylpenicillin inhibits the uptake of cilastatin by SLC22A8 [31]

Affected Drug/Substrate

 Cilastatin Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Dihydrotestosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dihydrotestosterone induces the activity of SLC22A8 [61]

Drug in Phase 3 Trial

  Benzylpenicillin

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzylpenicillin inhibits the transportation of Methotrexate by SLC22A8 (Ki = 97.6 microM) [14]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 2

 Benzylpenicillin inhibits the transportation of Fluorescein by SLC22A8 [7]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-OAT3

  DT Modulation 3

 Benzylpenicillin inhibits the activity of SLC22A8 [17]

  Pratosartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pratosartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.095 microM) [30]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

Drug in Phase 2 Trial

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A inhibits the activity of SLC22A8 [56]

Drug in Phase 1/2 Trial

  PRI-724

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 PRI-724 inhibits the activity of SLC22A8 [53]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

Drug in Phase 1 Trial

  Luteolin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Luteolin inhibits the activity of SLC22A8 [59]

  Quercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin inhibits the activity of SLC22A8 [59]

Drug in Preclinical Test

  Emodin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Emodin inhibits the activity of SLC22A8 [38]

Investigative Drug

  Adipate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Adipate inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 136 microM) [24]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Alpha-ketoglutaric acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alpha-ketoglutaric acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 92.8 microM) [24]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Glutarate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glutarate inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 78.5 microM) [24]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Aminohippuric acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aminohippuric acid inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 19.6 microM) [5]

Affected Drug/Substrate

 Ochratoxin A Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Angiotensinamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Angiotensinamide inhibits the activity of SLC22A8 [62]

  21H7

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 21H7 inhibits the activity of SLC22A8 [53]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

  FH535

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 FH535 inhibits the activity of SLC22A8 [53]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

  JBP485

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 JBP485 inhibits the uptake of imipenem by SLC22A6 [64]

Affected Drug/Substrate

 Imipenem Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

Drug Withdrawn

  Phenacetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenacetin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 19.4 microM) [12]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cephaloridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 2460 microM) [15]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Retigabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ezogabine inhibits the activity of SLC22A8 [60]

Natural Product

  Quercetin-3-O-glucuronide

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin-3-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 1.31 microM) [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  DT Modulation 2

 Quercetin-3-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 0.43 microM) [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Quercetin-3-O-sulfate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin-3-O-sulfate inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 0.75 microM) [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Gallic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gallic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 9 microM) [25]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Rosmarinic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rosmarinic acid inhibits the transportation of Estrone sulfate by SLC22A8 (Ki= 0.55 microM) [25]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Ursolic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ursolic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 19 microM) [25]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Rhein

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rhubarb inhibits the transportation of Estrone sulfate by SLC22A8 in a competitive manner (IC50 = 0.008 microM) [26]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Allethrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Allethrin inhibits the transportation of Fluorescein by SLC22A8 (IC50 = 69.4 microM) [27]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Tetramethrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetramethrin inhibits the transportation of Fluorescein by SLC22A8 (IC50 = 77.6 microM) [27]

Affected Drug/Substrate

 Fluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Citreoverdine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Citreoverdine inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.63 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Cyclopiazonic acid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A8 (IC50 = 1.9 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Fumonisin B1

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fumonisin B1 inhibits the transportation of Organic anion by SLC22A8 (IC50 = 181 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Daidzein-7-O-Glucuronide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Daidzein-7-O-Glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Genistein-7-O-glucuronide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistein-7-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Glycitein-7-O-glucuronide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glycitein-7-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 [18]

Affected Drug/Substrate

 5-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Cigarette smoke condensate (0.08mg/ml)

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate (0.08mg/ml) inhibits the activity of SLC22A8 [36]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Cigarette smoke condensate (0.32mg/ml)

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A8 [36]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution inhibits the activity of SLC22A8 [36]

  Chrysophanic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chrysophanic acid inhibits the activity of SLC22A8 [38]

  Wogonin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Wogonin inhibits the activity of SLC22A8 [59]

  Oroxylin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Oroxylin A inhibits the activity of SLC22A8 (IC50 = 0.112 microM) [63]

Cell System

 Human embryonic kidney 293 cells (HEK293)-SLC22A8

Dietary Constituent

  Danshen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Danshen inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 8.6 microM) [25]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT3

Environmental toxicant

  Bisphenol F

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol F inhibits the activity of SLC22A8 [56]

  Tetrabromobisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetrabromobisphenol A inhibits the activity of SLC22A8 [56]

  Sodium arsenate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenate increases the activity of SLC22A8 [36]

Mycotoxins

  DT Modulation 1

 Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A8 (IC50 = 1.9 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  DT Modulation 1

 Fumonisin B1 inhibits the transportation of Organic anion by SLC22A8 (IC50 = 181 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Aflatoxin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A8 (IC50 = 13.1 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Alpha-zearalenol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A8 (IC50 = 4.55 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Citrioveridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Citrioveridine inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.63 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Patulin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Patulin inhibits the transportation of Organic anion by SLC22A8 (IC50 > 1000 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Gliotoxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gliotoxin inhibits the transportation of Organic anion by SLC22A8 (IC50 = 73.9 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

  Zearalenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zearalenone inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.71 microM) [28]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT3

Acute Toxic Substance

  2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the activity of SLC22A8 [36]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene inhibits the activity of SLC22A8 [58]

Pesticide/Insecticide

  Clothianidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clothianidin inhibits the activity of SLC22A8 [57]

  Imidacloprid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Imidacloprid inhibits the activity of SLC22A8 [57]

Health and Environmental Toxicant

  Toluene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Toluene increases the expression of SLC22A8 [55]

  Lead chloride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lead chloride increases the activity of SLC22A8 [36]

Herbicide

  Atrazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atrazine increases the expression of SLC22A8 [54]
References
1 Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J Pharmacol Exp Ther. 2007 May;321(2):673-83.
2 In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol. 2012 Apr;52(4):530-42.
3 Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol. 2001 May 11;419(2-3):113-20.
4 Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos. 2006 May;34(5):743-7.
5 Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001 Sep 21;69(18):2123-35.
6 Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods. Drug Metab Dispos. 2013 Jan;41(1):149-58.
7 Organic anion transporter 3 interacts selectively with lipophilic beta-lactam antibiotics. Drug Metab Dispos. 2013 Apr;41(4):791-800.
8 Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1). J Pharmacol Exp Ther. 2010 Sep 1;334(3):936-44.
9 Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol. 2003;146:95-158.
10 Interactions of organic anions with the organic cation transporter in renal BBMV. Am J Physiol. 1988 Jan;254(1 Pt 2):F56-61.
11 Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
12 Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 Nov;303(2):534-9.
13 In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate. Eur J Pharm Sci. 2011 May 18;43(1-2):41-9.
14 Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
15 Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol. 2003 Mar 28;465(1-2):1-7.
16 Scintillation proximity assay for measuring uptake by the human drug transporters hOCT1, hOAT3, and hOATP1B1. Anal Biochem. 2007 Jul 15;366(2):117-25.
17 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 2004 Sep;145(9):4384-91.
18 Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol. 2011 Apr 1;81(7):942-9.
19 Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Eur J Pharmacol. 2004 Jan 12;483(2-3):133-8.
20 Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica. 2007 Apr;37(4):416-26.
21 Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine. Clin Pharmacol Ther. 2022 Sep;112(3):653-664.
22 Factors Associated With Neurological Outcome After Childhood Stroke-Reply. JAMA Neurol. 2016 Oct 1;73(10):1257-1258.
23 Novobiocin is a potent inhibitor for human organic anion transporters. Drug Metab Dispos. 2009 Jun;37(6):1203-10.
24 Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am J Physiol Renal Physiol. 2011 Nov;301(5):F1026-34.
25 Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs. J Food Drug Anal. 2018 Apr;26(2S):S45-S60.
26 The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination. Biochem Pharmacol. 2013 Oct 1;86(7):991-6.
27 Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin. PLoS One. 2017 Jan 18;12(1):e0169480.
28 Interactions of organic anion transporters and organic cation transporters with mycotoxins. J Pharmacol Sci. 2008 Mar;106(3):435-43.
29 OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam. Int J Pharm. 2018 Feb 15;537(1-2):172-182.
30 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
31 Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. Asian J Pharm Sci. 2020 Mar;15(2):252-263.
32 Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40. Neoplasia. 2023 May;39:100891.
33 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
34 Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat. Drug Metab Dispos. 2014 Jun;42(6):996-1007.
35 Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol. 2008 Apr;294(4):F867-73.
36 Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate. Toxicol In Vitro. 2017 Oct;44:27-35.
37 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92.
38 From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity. Toxicol Sci. 2018 Feb 1;161(2):321-334.
39 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384.
40 Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem. 2007 Aug 17;282(33):23841-53.
41 Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharmacol. 2008 Jul;74(1):122-31.
42 Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters. Br J Clin Pharmacol. 2006 Sep;62(3):323-35.
43 Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3). Drug Metab Lett. 2011 Apr;5(2):140-37.
44 Drug interaction between celecoxib and methotrexate in organic anion transporter 3-transfected renal cells and in rats in vivo. Eur J Pharmacol. 2010 Aug 25;640(1-3):168-71.
45 Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet. 2010;25(5):450-5.
46 JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats. Toxicol Lett. 2018 Oct 1;295:195-204.
47 The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models. Eur J Pharm Sci. 2018 Mar 30;115:132-143.
48 Role of efflux transporters in the absorption, distribution and elimination in rodents of a novel PDE4 inhibitor, CHF6001. Eur J Pharm Sci. 2018 Mar 30;115:100-108.
49 Evidence of post-transcriptional readthrough regulation in FGF5 gene of alpaca. Gene. 2018 Mar 20;647:121-128.
50 The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag. Xenobiotica. 2018 Jul;48(7):704-719.
51 Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3. Drug Metab Dispos. 2016 Oct;44(10):1543-9.
52 Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. Drug Metab Dispos. 2016 Mar;44(3):453-9.
53 Impaired Transport Activity of Human Organic Anion Transporters (OATs) and Organic Anion Transporting Polypeptides (OATPs) by Wnt Inhibitors. J Pharm Sci. 2021 Feb;110(2):914-924.
54 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
55 Association analysis of toluene exposure time with high-throughput mRNA expressions and methylation patterns using in vivo samples. Environ Res. 2016 Apr;146:59-64.
56 Inhibition of SLC drug transporter activities by environmental bisphenols. Toxicol In Vitro. 2017 Apr;40:34-44.
57 Neonicotinoid pesticides poorly interact with human drug transporters. J Biochem Mol Toxicol. 2019 Oct;33(10):e22379.
58 Involvement of aryl hydrocarbon receptor in the cytotoxicity of corannulene and its derivatives. Toxicol Lett. 2020 Mar 15;321:114-121.
59 Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy. Toxicol Sci. 2020 Jun 1;175(2):279-291.
60 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG02866)
61 Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers. J Cell Physiol. 2005 Sep;204(3):896-900.
62 Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter. Eur J Pharmacol. 2010 Feb 10;627(1-3):49-55.
63 Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid. Chem Biol Interact. 2020 Jun 1;324:109097.
64 JBP485, A Dual Inhibitor of Organic Anion Transporters (OATs) and Renal Dehydropeptidase-I (DHP-I), Protects Against Imipenem-Induced Nephrotoxicity. Front Pharmacol. 2022 Jun 8;13:938813.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.